Financial Report Analysis: HGH Holdings Ltd.

Company Overview
HGH Holdings Ltd. is a company incorporated in the Republic of Singapore, with a focus on providing materials and services for the construction industry. The company’s core business operations, business segments, and geographic footprint are not explicitly stated in the report.
Business Description
The company’s core business operations seem to be related to the construction industry, given the mention of concrete batching plants, precast concrete products, and property development.
Industry Position and Competitors
Although not explicitly stated, the company’s operations and financials suggest that it is a small player in the construction industry, with a relatively modest market presence.
Revenue Streams, Customer Base, and Supply Chain
The company’s revenue streams seem to be primarily related to its construction and property development activities. However, there, the report does not provide detailed information on its customer base or supply chain.
Financial Analysis
Income Statement
The company’s revenue for the financial year ended 31 December 2024 (FY2024) was SGD 21,318,000, with a gross profit of SGD 6,077,000. The net profit for the year was SGD 233,000.
Balance Sheet
The company’s total assets were SGD 69,246,000, with total liabilities of SGD 23,316,000. The equity of the company stood at SGD 45,930,000.
Cash Flow Statement
The company’s net cash used in financing activities was SGD (1,723,000), primarily due to the repayment of lease liabilities and interest paid.
Key Findings and Recommendations
Compelling Reasons for Investor Action
The company’s revenue decreased by SGD 4,000, or 0.02%, from SGD 21,322,000 to SGD 21,318,000.
The company’s net profit increased by SGD 81,000, or 53.3%, from SGD (152,000) to SGD (233,000).
The company’s dividend proposal is not mentioned in the report.
Financial Performance
Revenue: SGD 21,318,000 (unaudited) vs. SGD 21,322,000 (audited), a decrease of 0.02%.
Gross Profit: SGD 6,077,000 vs. SGD 6,107,000, a decrease of 0.5%.
Net Profit: The company’s net profit increased by 53.3% from SGD (152,000) to SGD (233,000).
Risks and Concerns
The company’s financial performance seems to be stable, but there are some areas of concern, such as the decrease in revenue and the increase in total liabilities by 2.1%.
Important Information for Investor Action
Earnings Increase/Decrease: The company’s net profit increased by SGD 81,000.
Dividend: No dividend information is provided in the report.
Special Activities or Actions
The company has taken steps to improve its profitability, such as:
Reclassification of supplier’s refund from other current assets to trade and other receivables.
Adjustment of deferred tax provision.
Date of Report and Financial Year
The report is dated 11 April 2025 and is for the financial year ended 31 December 2024.
Recommendation
Based on the analysis, we recommend that:
Current Shareholders: Hold their positions, as the company’s financial performance seems stable, and the decrease in revenue is relatively minor.
Potential Investors: Exercise caution when dealing with the company’s shares, as there are some areas of concern, such as the increase in total liabilities and the decrease in revenue.
Disclaimer: This recommendation is based solely on the information provided in the report and should not be considered as investment advice. The reader should do additional due diligence before making a decision.
Please consult a financial advisor for further guidance.
The information is based on available data and may not reflect the current market situation.

View HGH Historical chart here